[Discussion] the 503A advice in here is 2 years out of date
the 503A advice in here is 2 years out of date. I have gone back and forth on this for months. The numbers the title promised, since a headline without them is worthless: 2 years. Everything below is context for those. A 503A pharmacy compounds for an identified patient against a prescription. A 503B outsourcing…
I would not read the price difference as a quality signal. Most of it is the consultation model, not the vial.
What did the intake actually ask you?
do not assume the concentration matches the branded product
a 503B has to register and report, so there is a paper trail to ask for
ask which facility, then ask for their testing
Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.
the label on a compounded vial is a legal document, read it
I would not read the price difference as a quality signal.
This is the distinction the whole board runs on. Everything else follows from it.
Correcting my own comment: the shortage status changed in the interim, so the arrangement I described no longer applies.
shortage status changes and the whole arrangement changes with it
shortage status changes and the whole arrangement changes with it
usp_appendix is right about the concentration trap. It breaks arithmetic that has been reliable for months.